FREMONT, Calif. and OXFORD, United Kingdom, Feb. 11, 2021 /PRNewswire/ -- Cerus Endovascular Ltd., a privately-held, commercial-stage medical device company, today announced that it has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its Contour Neurovascular System™.
Bochum, 10th February 2021. Despite a challenging year 2020, Phenox GmbH is pursuing its strategic plans in strengthening the footprint in key markets across Europe. As part of this strategy and in the light of Brexit, Phenox has taken the decision to open a UK entity materialising in its new office south of Birmingham.
